(Q73145564)
Statements
Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials (English)
L Truyen
F Barkhof
M Tas
M A Van Walderveen
S T Frequin
O R Hommes
J J Nauta
C H Polman
1 January 1997